Integrative Physicians Providing Holistic Cancer Treatment Options for Early,
Late-Stage, and Metastatic Cancer
A cancer diagnosis does not have to put the brakes on your dreams, aspirations, and life! At Envita Medical Centers,
a
world-class integrative Center of Excellence for Precision Oncology, cancer patients have access to more targeted
treatments and a chance to live life once again, despite being written off by standard cancer specialty treatment
centers. Our integrative physicians combine the latest in conventional cancer treatment with advanced alternative
therapies to go beyond the scope of standard chemotherapy, radiation, and invasive surgeries.
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please
consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or
achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
Envita’s Personalized Blueprint Treats Cancer at its Core
We use our unique precision algorithms to harness the power of new treatments developed over decades of cancer
research,
and strike at the core of each patient's unique genetic mutations that are driving their cancer. These genetic
mutations
could be due to various causes, such as chemicals, toxins, diet, lifestyle, or inherited factors. Irrespective of the
causative factor, we identify the mutations at the cellular genetic level to treat the disease holistically, down to
its
source.
Cancer is a disease of genetic mutations, and genetics vary from person to person, which is why personalization is
key
to effectively treating this disease. We personalize a medical blueprint to impact each patient’s specific cancer
expressions, with the aim of progressing towards a cure for cancer.
As described by the National Cancer Institute, our integrative approach perfectly blends conventional medicine with
other treatments for cancer, like complementary and alternative medicine. However, our complementary therapies do not
include unproven alternative cancer treatments like tai chi, music therapy, or aromatherapy and our treatment modality
goes far beyond dietary supplements and focuses on full-body nutritional support to strengthen the immune system.
Our multi-level cancer therapy treats patient-specific genetic targets and other cancer feeders with the most
advanced
precision-targeted technologies. We aim to not only kill the existing cancer cells in your body, but also reduce
chances
of future growth or spread by reactivating your immune system. To rebuild a stronger immune system, we utilize
innovative immunotherapies for all stages and types of cancer.
All designed to help our patients achieve a greater chance at treatment success.
We believe human life is a gift worth fighting for; we have a responsibility to provide truly
personalized and precision-targeted care options from an unparalleled team to help save and extend human
life.
You may be wondering, “What are these precision-targeted
technologies and why hasn’t my current cancer treatment plan worked?”
Read on to know how Envita Medical Centers can make a difference:
Precision-Targeted Care to Overcome Treatment Failure
Like no other time in history, we have more options and targeted technologies to make the best cancer treatment plan,
which is comprehensive enough to check failures. These advancements can be beneficial for the patients who have
exhausted previous standard treatment options and even alternative therapies, with no success. Both of these aspects
of
medical care have to be precision-targeted to each patient's unique cancer expressions, for minimizing the risk of
chemotherapeutic drug resistance, one of the potential side effects of cancer treatment.
Chemotherapeutic drug resistance is believed to
cause treatment failure in over 90% of patients with metastatic cancer.
Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J
Pathol. 2005;205(2):275–92.
What is Chemotherapeutic Drug Resistance?
Chemotherapeutic drug resistance, also known as multidrug resistance (MDR), is the result of multiple
rounds of untargeted chemotherapy being administered without the cancer responding to the treatment.
The cancer cell’s ability to reduce the intake of chemotherapy drugs while at the same time activating
its ability to push out the hazardous drugs that have entered the cell, is responsible for the
development of resistance to chemotherapy. Learn
more about Chemotherapeutic Drug Resistance
Cancer Cell Pumping Out Untargeted
Chemotherapy
Drugs
Cancer Cell Pumping Out Untargeted Chemotherapy Drugs
Advanced N-of-1 Treatment
At Envita, we follow the N-of-1 treatment model, which is designed to personalize a
medical blueprint for each individual patient, improving their chances of response to treatment. This approach of
custom-building an entire treatment plan is in direct contrast with standard oncology, where a suitable treatment is
sought from the existing pool of options, based on cancer type and stage.
You may be asking yourself, “Why aren’t all cancer centers using precision for everyone?”
In our 25 years of clinical experience, we find that custom building a medical blueprint for each patient
provides precision treatment options, which help to avoid multidrug resistance in early cases of cancer and
overcome it in late-stage cancer cases as well.
According to the NCCN (National Comprehensive Cancer Network) guidelines,
which drive standard oncology, a patient is
treated based on their cancer type and stage. If the standardized medical treatment fails numerous times, then the
patient becomes eligible for genomic analysis to identify precision treatment targets.
Our clinical experience proves how crucial an extensive genomic analysis is to understand your specific cancer cell
mutations which drive treatment. This detailed analysis is the first step towards precision oncology, but not everyone
has access to it in the standard model of cancer care.
Even those limited few who get access to precision treatments in standard oncology do not get the benefit of an
extensive genetic analysis to the level Envita provides for its patients.
Envita Precision Algorithm vs. Standard Oncology Precision Testing
Envita Medical Centers
Standard Oncology Precision Testing
RNA Transcriptome Genes
Envita Medical Centers:20,000+
Standard Oncology:Unchecked
SNV/CNV Genes
Envita Medical Centers:452
Standard Oncology:309
Rearrangements/Fusion Genes
Envita Medical Centers:51
Standard Oncology:27
Microsatellite Instability (MSI)
Envita Medical Centers:Checked
Standard Oncology:Checked
Tumor Mutation Burden (TMB)
Envita Medical Centers:Checked
Standard Oncology:Checked
BRCA 1/2
Envita Medical Centers:Checked
Standard Oncology:Checked
Immunohistochemistry
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Chemosensitivity
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Concurrent Liquid Biopsy
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Exosomal miRNA Analysis
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Circulating Tumor Cells Enumeration
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Pharmacogenomics
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Individualized Therapy Recommendation
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Carcinogenic Exposure - Root Causes
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Inflammation Markers
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Metabolic Target Drivers
Envita Medical Centers:Checked
Standard Oncology:Unchecked
*Individual results may vary. Envita
makes no guarantees for outcomes.
Precision Oncology to Counter Metastasis
In the standard oncology world, care is determined by NCCN guidelines which groups patients of the same cancer
type and stage to receive the same standard treatment regimen yielding differing results.
The challenge in cancer treatment lies in tackling multidrug resistance while building the immune system to lessen
the
chances of recurrence and metastatic spread. The treatments deployed in standard cancer treatment centers and
hospitals
are often reactive and not proactive. They are not designed to enhance the immune system, prevent cancer spread, or
prevent recurrence, nor do they consider how the cancer is changing and mutating.
Cancer is a disease of genetic mutations, messaging, and immunity, not of only tissue/tumor type and staging
patterns.
Cancer immunity and genomic targeting varies from person to person, which highlights the need for precision
and
personalization in cancer care.
At Envita we treat cancer like a bird in flight, we are aiming for where the cancer will be, not where it has been.
Envita’s personalized precision oncology is designed on a four-pillared approach to help counter metastasis and
overcome
the limitations in standard oncology. We take cancer patient treatment to new heights with the goal of improving
quality
of life, increasing longevity, and reducing toxicity.
Step 1
Exhaustive Personalized DNA Testing
At Envita, the first step towards precision oncology is to perform an extensive genomic analysis of
each individual patient to understand their specific genomic, transcriptomics, proteomics, and
metabolomics. Understanding all these parameters is crucial to treating your cancer triggers, so we
don’t just manage your disease but shut off its drivers.
In standard oncology, the aspect of strengthening the immune system is often
overlooked, but a strong
and robust immune system can detect cancer cells and kill them instantly. In fact, a strong immune
system kills around 10,000 cancer cells every day, but a weakened immune system is unable to achieve
this target, which is what ultimately led to cancer developing in the first place.
These refer to each patient's specific cancer cell mutations, which also help in monitoring
treatment responses.
Transcriptomics (miRNA)
The messaging and signaling at the molecular levels, which affect your cancer growth and spread.
Proteomics (Protein)
Complements genomic and transcriptomic data to help better understand each patient's individual
cancer cell physiology.
Metabolomics (Metabolite)
Understanding metabolomics is crucial for enhancing efficacy of integrative adjuvant care and
overall treatment.
In standard oncology, the aspect of strengthening the immune system is often
overlooked, but
a strong
and robust immune system can detect cancer cells and kill them instantly. In fact, a strong immune
system kills around 10,000 cancer cells every day, but a weakened immune system is unable to achieve
this target, which is what ultimately led to cancer developing in the first place.
Envita Extensive Genomic Analysis vs. Standard DNA Testing
Envita Medical Centers
Standard DNA Testing
Genomics (DNA)
Envita Medical Centers:452
Standard DNA Testing:309
Transcriptomics (miRNA)
Envita Medical Centers:20,000+
Standard DNA Testing:Unchecked
Proteomics (Protein)
Envita Medical Centers:Checked
Standard DNA Testing:Unchecked
Metabolomics (Metabolite)
Envita Medical Centers:Checked
Standard DNA Testing:Unchecked
*Individual results may vary. Envita
makes no guarantees for outcomes.
Your immune system is your first and last line of defense against cancer.
Step 2
Immuno Targeting With Envita’s Ultra Analytes Liquid Biopsy - A
Solution to Traditional Tissue Biopsies
Envita’s Ultra Analytes Liquid Biopsy helps to overcome the limitations of traditional tissue biopsies performed
in standard oncology, by analyzing the freshest genetic mutations derived from the circulating tumor cells (CTC)
floating in the patient’s blood.
Analyzing these CTCs gives us the most current cancer biomarkers targets, so we can identify how your cancer
is changing and mutating. This analysis leads to precision drug design and treatment, not only for the tumor but for
the small metastatic CTCs,
which may lower the chances of recurrence.
Ultra Analytes Liquid Biopsy
Ultra Analytes Liquid Biopsy is deployed to identify targeted immunotherapy options to help get your
immune system working properly again.
Learn more
about
Immunotherapy
Determining the latest biomarkers through our Ultra Analytes Liquid Biopsy leads us to the most actionable
targets for chemotherapeutic agents, adjuvant therapies, and immunotherapy targets your body is most likely to
respond to.
Personalized Drug Design Unique to Each Patient’s Cancer
Once immuno targeting is complete, we custom-build each patient’s medicines at our in-house pharmacy,
based on the genomic liquid biopsy findings. The result of the liquid biopsy provides us numerous details
about your latest cancer mutations. From this data we are able to use multiple drug and adjuvant agents
targeted to your needs.
We now know how your cancer is changing and we can determine what medicines may
be best suited to target your cancer.
We now know how your cancer is changing and we can determine what medicines may be best
suited to target
your cancer.
Envita Medical Centers Medical Team
Physicians with MD, NMD, DO, DO(h), MD(h), medical licenses
22
Pharmacists specializing in integrative agents
7
Nurses trained in precision treatment delivery
40+
Our 2020 data showed an improvement in quality of
life and a 95% reduction of side-effects in our patients compared to
their previous treatments at other cancer centers.
* The 3rd party actuarial response data is based on an analysis of records for
87 out of 129 patients that participated
in Envita’s Treatment Program in 2020. 42 patients were removed from the cohort due to the patients’ inability to
start
or complete Envita’s prescribed treatment for a variety of reasons, including but not limited to, advanced disease
state, disease progression, or inability to travel.
Envita’s personalized precision oncology treatments involve deep levels of targeting, which helps us
enhance our
mechanisms of cancer kill so we can put our patients on a road to recovery.
Step 4
Precision Deployment of Proprietary Treatments to Enhance Tumor Kill
To minimize the adverse effects of untargeted chemotherapy, radiation therapy, and surgery as seen in standard
oncology,
Envita has developed a proprietary suite of treatments and technology that are proving advantageous to kill cancer
cells
without impacting the adjoining healthy cells. All our therapies for cancer are aimed at deploying our
patient-specific
chemo and immuno medications in a precision targeted approach, enabling us to optimize the efficacy of our treatment
with the goal of long-term remission.
GTFC™ is Envita’s proprietary form of low-dose fractionated chemotherapy that can hit up to 7-10 genetic biomarkers
and
mechanisms of tumor kill at once, something traditional chemotherapy simply cannot do. Our extensive genomic analysis
helps us take the guesswork out of treatment and deliver chemotherapy at metronomic or fractionated doses that are far
less toxic and better matched than standard maximum therapeutic doses, providing a precision advantage for our
patients.
Envita's GTFC™ vs. Standard Chemotherapy
Envita Medical Centers
Standard Chemotherapy
Helps to improve chemotherapy delivery to the tumor using a "Trojan Horse" delivery mechanism.
Envita's GTFC™:Checked
Standard Chemotherapy:Unchecked
Uses genetic molecular profiling to understand all the facets of each patient's specific cancer.
Envita's GTFC™:Checked
Standard Chemotherapy:Unchecked
Uses targeted treatment to enhance the mechanism of cancer kill.
Envita's GTFC™:Checked
Standard Chemotherapy:Unchecked
Uses microdosed (fractionated) chemotherapies, reducing the chances of impacting healthy cells.
Envita's GTFC™:Checked
Standard Chemotherapy:Unchecked
Minimizes toxicity to normal cells, lowering the chance of side-effects related to administration.
Envita's GTFC™:Checked
Standard Chemotherapy:Unchecked
Uses patient-specific supportive immunotherapy to strengthen the immune system.
Envita's GTFC™:Checked
Standard Chemotherapy:Unchecked
Aims to reduce multidrug resistance by administering 10 - 20% of the medication delivered in maximum dose
chemo.
Envita's GTFC™:Checked
Standard Chemotherapy:Unchecked
Allows custom-compounded medications to be readministered in tandem to suit each patient's individual cancer
mutations.
Envita's GTFC™:Checked
Standard Chemotherapy:Unchecked
*Individual results may vary. Envita
makes no guarantees for outcomes.
CIPI™ is a minimally invasive image-guided surgery that allows for direct deployment of personalized
anti-cancer agents, right into the tumor with maximum absorption. This interventional radiology procedure shuts down
the tumor and cuts off its blood supply, which can lead to
significantly reducing toxicity to the body and increasing recovery times over standard surgery.
Envita's CIPI™ vs. Standard Surgery
Envita Medical Centers
Standard Surgery
Minimally invasive so it can be performed within 40-50 minutes, without the need for large surgical
incisions.
Envita's CIPI™:Checked
Standard Surgery:Unchecked
Can be performed multiple times, even at close intervals, because there is minimal risk of post-op
complications.
Envita's CIPI™:Checked
Standard Surgery:Unchecked
No need for general anesthesia, reducing the health risks that can result from being put into a
medically induced coma to perform an invasive surgery.
Envita's CIPI™:Checked
Standard Surgery:Unchecked
Faster recovery time as compared to traditional surgery, due to the minimally invasive administration.
Envita's CIPI™:Checked
Standard Surgery:Unchecked
Provides direct tumor targeting, which delivers patient-specific genomic agents into the tumor.
Envita's CIPI™:Checked
Standard Surgery:Unchecked
Causes a systemic immune response where the immune system is reactivated to find and attack other
metastatic cancer sites in the body.
Envita's CIPI™:Checked
Standard Surgery:Unchecked
Performed by highly trained medical professionals in an outpatient setting, so there is no need of
hospital stays for recovery.
Envita's CIPI™:Checked
Standard Surgery:Unchecked
*Individual results may vary. Envita
makes no guarantees for outcomes.
Choosing Envita’s cancer specialists for your treatment may be one of the best decisions you ever make. But don’t
take
our word for it, hear from our cancer survivors to see how Envita is changing their lives.
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please
consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or
achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
With over 25 years of clinical experience in treating complicated and late-stage cancers, team Envita is focused on
helping every cancer patient reclaim their life! If you or a loved one is suffering from any type of cancer, Envita
Medical Centers’ advanced Precision Oncology options may have the potential to lead you towards a holistic recovery,
irrespective of the stage of cancer. Our integrative physicians are specially trained for over 1,500 hours in this
personalized precision oncology approach to help potentiate treatment responses.
Our medical staff is well trained and able to answer any questions you might have.
May God bless you on your journey to healing!
Choose Envita Medical Centers
Our team is ready to help you get your life back! Please enter your contact information and a Patient Care
Expert will contact you shortly. If you would rather speak now, please give us a call at 1-866-830-4576.
